DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation

Authors

  • Momin Mohammad Fuzail Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Barrawaz Aateka Yahya Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Shaikh Shoaib Iftekhar Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.
  • Sarfaraz Khan Maulana Azad Educational Trust’s Y. B. Chavan College of Pharmacy, Aurangabad, Maharashtra, India.

DOI:

https://doi.org/10.56511/JIPBS.2026.13108

Abstract

Background: Most computational drug repurposing systems generate predictions without providing mechanistic justification, biological context, or clinical evidence. This disconnect between prediction and understanding limits practical adoption by pharmaceutical researchers. Objective: To design and validate an integrated platform combining knowledge graph embedding-based prediction with multi-level biological validation for drug repurposing hypothesis generation. Methods: A RotatE knowledge graph embedding model was trained on a DrugBank-derived knowledge graph containing 16,698 entities and 2.94 million relational triples using PyKEEN. The prediction engine was wrapped in a validation architecture comprising dual-tiered explainability (path-based and embedding-based reasoning), disease pathway analysis, drug target identification with druggability scoring, biomarker discovery via transcriptomic reversal analysis, chemical similarity search, ClinicalTrials.gov integration, literature mining, pharmacovigilance-based safety profiling, and novelty assessment. Results: Internal validation against RepoDB yielded an MRR of 0.422, Hits@10 of 65.4%, and AUC-ROC of 0.847. External validation against the independent PREDICT dataset produced Hits@10 of 40%, confirming cross-dataset generalization. Case studies on Metformin and Hydroxychloroquine demonstrated the system across known associations, novel embedding-based predictions, and path-supported hypotheses with convergent biological evidence from pathway, transcriptomic, and chemical similarity analyses. Conclusion: Knowledge graph embeddings, when integrated within structured biological validation, can produce drug repurposing hypotheses that are scientifically defensible and clinically contextualized. The multi-level evidence architecture transforms numerical predictions into testable scientific hypotheses suitable for guiding early-stage experimental investigation.

Keywords:

Drug repurposing, knowledge graph embeddings, RotatE, explainable AI, biological validation, pharmacovigilance, pathway analysis

Downloads

Download data is not yet available.

References

DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20 - 33.

Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40 - 51.

Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41 - 58.

Himmelstein DS, Lizee A, Hessler C, Brueggeman L, Chen SL, Hadley D, et al. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife. 2017;6:e26726.

Zhang Y, Li X, Guo Y, Shi Y, Liu J, Wang Z. Machine learning and deep learning approaches for drug repurposing. Curr Med Chem. 2021;28(14):2700 - 18.

Wang Q, Mao Z, Wang B, Guo L. Knowledge graph embedding: a survey of approaches and applications. IEEE Trans Knowl Data Eng. 2017;29(12):2724 - 43.

Sun Z, Deng ZH, Nie JY, Tang J. RotatE: Knowledge graph embedding by relational rotation in complex space. In: Proceedings of the International Conference on Learning Representations (ICLR); 2019.

Zeng X, Song X, Ma T, Pan X, Zhou Y, Hou Y, et al. Repurpose open data to discover therapeutics for COVID - 19 using deep learning. J Proteome Res. 2020;19(11):4624 - 36.

Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database. Nucleic Acids Res. 2018;46(D1):D1074 - D1082.

Brown AS, Patel CJ. A standard database for drug repositioning. Sci Data. 2017;4(1):170029.

Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications. Mol Syst Biol. 2011;7(1):496.

Ali M, Berrendorf M, Hoyt CT, Vermue L, Galkin M, Sharifzadeh S, et al. PyKEEN 1.0: a Python library for training and evaluating knowledge graph embeddings. J Mach Learn Res. 2021;22(82):1 - 6.

Jimenez - Luna J, Grisoni F, Schneider G. Drug discovery with explainable artificial intelligence. Nat Mach Intell. 2020;2(10):573 - 84.

Mohamed SK, Novacek V, Nounu A. Discovering protein drug targets using knowledge graph embeddings. Bioinformatics. 2020;36(2):603 - 10.

Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796 - 803.

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene - expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929 - 35.

Published

30-06-2026
Statistics
145 Views | 224 Downloads

How to Cite

Momin Mohammad Fuzail, Barrawaz Aateka Yahya, Shaikh Shoaib Iftekhar, and Sarfaraz Khan. “DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing With Multi-Level Biological Validation”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 13, no. 1, June 2026, pp. 67-75, doi:10.56511/JIPBS.2026.13108.

Issue

Section

Research Article